Synthesis and Properties of Amphiphilic Photoresponsive Gelators for Aromatic Solvents
摘要:
A sugar-based photoresponsive supergelator, N-glycosylazobenzene that shows selective gelation of aromatic solvents is described. The partial trans-cis isomerization of the azobenzene moiety allows photoinduced chopping of the entangled gel fibers to short fibers, resulting in controlled fiber length and gel-sol transition. The gelator is useful for the selective removal of toxic aromatic solvents from water.
Insights into a novel class of azobenzenes incorporating 4,6-<i>O</i>-protected sugars as photo-responsive organogelators
作者:P. V. Bhavya、V. Rabecca Jenifer、Panneerselvam Muthuvel、T. Mohan Das
DOI:10.1039/c9ra08033c
日期:——
A novel class of 4,6-O-butylidene/ethylidene/benzylidene β-D-glucopyranose gelator functionalized with photo-responsiveazobenzene moieties were designed and synthesized and also characterized using different spectral techniques. These azobenzene-based organogelators can gel even at lower concentrations (critical gelation concentration – 0.5% and 1%). A morphological study of the gels shows one-dimensional
Design and synthesis of sugar-benzohydrazides: low molecular weight organogelators
作者:Kamalakannan Soundarajan、Rathinam Periyasamy、Thangamuthu Mohan Das
DOI:10.1039/c6ra18715c
日期:——
A novel class of methyltriglycol benzohydrazide based N-glycosylamines containing long alkyl chain derivatives were synthesized in good yield and characterized using NMR (1H and 13C) spectral analysis. The gelation test shows that these derivatives form gels with a wide range of polar (1,2-dichlorobenzene, chloroform) and non-polar (1,2-dichloroethane, toluene, benzene) solvents even with lower CGC
Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
申请人:Jenkins John
公开号:US20050245466A1
公开(公告)日:2005-11-03
The present invention relates to the use of a first agent that attenuates topoisomerase II (Topo II) activity and a second agent that inhibits Heat Shock Protein 90 (HSP90) for use in chemotherapy. The agents are particularly useful in the treatment of cancer and destruction of micro-organisms. The invention also relates to screening methods, diagnostic methods and methods for evaluating or monitoring chemotherapy regimens.